Curious about Edwards Lifesciences (EW) Q3 Performance? Explore Wall Street Estimates for Key MetricsZacks Investment Research • 4h
Edwards Lifesciences Continually Innovating Ahead Of Q3 Results, Cardio Portfolio ThrivesSeeking Alpha • Thursday
FDA Approval of Edwards Lifesciences' PASCAL Precision System Opens New Treatment Pathway for Patients With Tricuspid Valve DiseaseBusiness Wire • 10/21/26
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric PatientsBusiness Wire • 10/01/26
Edwards Lifesciences Corporation (EW) Presents at Deutsche Bank 2026 Healthcare Summit TranscriptSeeking Alpha • 09/16/26
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?PRNewsWire • 09/07/26
Is EW Stock Worth Buying as Growth Clashes With a Premium Valuation?Zacks Investment Research • 08/14/26
Edwards Climbs 14% in 3 Months as Growth Strength Tests ValuationZacks Investment Research • 08/13/26
Is the Options Market Predicting a Spike in Edwards Lifesciences Stock?Zacks Investment Research • 07/30/26